Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:34 PM
Ignite Modification Date:
2025-12-24 @ 3:34 PM
NCT ID:
NCT02710292
Eligibility Criteria:
Inclusion Criteria:
* Must sign an informed consent form;
* Habitual current daily disposable soft contact lenses wearer;
* Symptoms of contact lens discomfort as defined by the Symptomatology (Eligibility) Questionnaire;
* Lenses within the power range specified in the protocol;
* Vision correctable to 20/25 or 0.1 logMAR (logarithmic minimum angle of resolution) or better in each eye at distance with pre-study contact lenses at Visit1;
* Acceptable lens fit with both study contact lenses;
* Willing to wear lenses every day or at least for a minimum of 10 days, 6 hours per day, every day if possible and attend all study visits;
* Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
* Currently wearing DT1 or TE sphere lenses;
* Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
* Use of systemic or ocular medications in which contact lens wear could be contraindicated as determined by the investigator;
* Eye injury or surgery within 12 weeks immediately prior to enrollment;
* History of herpetic keratitis, ocular surgery or irregular cornea;
* Prior refractive surgery;
* Monocular (only 1 eye with functional vision) or fit with only 1 lens;
* Participation in any clinical trial within 30 days of the enrollment visit;
* Other protocol-specified exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02710292
Study Brief:
Protocol Section:
NCT02710292